Monthly Archives: September 2009

RockyRadar Thanks Our Sponsors

RockyRadar would like to thank our sponsors, without whom complete coverage of the Colorado technology sector would not be possible:
Ubiquity Group recently designed and launched the Fitzsimons BioBusiness Partners website. The site was created to highlight the mission of FBBp as well as offer a window to the companies operating within the facility. Says Michael [...]

Becton Dickson Declines Option for Accelr8 Bacterial Identification Technology

Accelr8 Technology Corporation announced that it has concluded its technical development project with Becton, Dickinson and Company (BD). While Accelr8’s technology met several testing requirements related to the identification of specific species of bacteria, BD declined to execute an exclusive license option for the technology. Accelr8’s BACcel system has proven capable of rapidly [...]

The Week Ahead: September 28 – October 5

This week kicks off on Monday with the year’s first Entrepreneur’s Unplugged featuring Niel Robertson, a Startup Junkie Underground discussing the art of hiring, as well as Agile and Visual Studio User Groups.  The middle of the week sees two clean tech events both hosted at the Metro Denver Chamber of Commerce: a Colorado Cleantech [...]

What We’re Reading

Guinness getting hard to come by: It used to be that scoring a Guinness World Record was as simple as growing out your fingernails or throwing a giant cupcake in the oven (or so it seemed). But with the world continuing to careen toward greater extremes, bagging a coveted Guinness title has become a bit [...]

FDA Approves Allos’ Folotyn for Lymphoma Subtype

Allos Therapeutics announced that last night the FDA had granted accelerated approval for Folotyn (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), following the 10 to 4 recommendation of its oncology committee made at the beginning of the month. This decision [...]

DailyBurn and Occipital Launch FoodScanner iPhone App

Today, two TechStars alumni announced they have formed a partnership to release the iPhone app FoodScanner, a food journal application that incorporates a barcode scanner to let users quickly input multiple variables of nutritional information. DailyBurn is the fastest growing fitness site on the web with over 250,000 users, and Occipital LLC developed RedLaser, which [...]

OneRiot Launches Developer Network

OneRiot today announced the launch of its OneRiot Developer Network (ORDN), the official support network for OneRiot API partners. The network will be led by OneRiot co-founder Robert Reich. Based in Boulder, Colorado, OneRiot is a real-time search engine that seeks to find the pulse of current web conversations across traditional and social [...]

TopSchool Software Manages Students from Initial Inquiry to Fifty Year Reunion

Matthew Schnittman, President and CEO of the software company TopSchool, does not lack for passion in discussing the overall importance of higher education: “Education in the United States is the backbone that will help our society, economy, and communities remain key players on the global stage. For-profit organizations are pushing education at large to become [...]

Rocky Mountain Life Science Investor Conference Presenting Companies – Part 2

Below are recaps of another 12 of the presenting companies at the Rocky Mountain Life Science Investor Conference.
Medipacs (Tuscon, Arizona) is in clinical development with a disposable infusion pump for drug delivery. The Mini-Infuser pump – about the size of a drink coaster – is worn by the patient and utilizes a novel polymer actuator [...]

Rocky Mountain Life Science Investor Conference Companies – Part 1

Below are brief descriptions of 11 of the companies that presented on Thursday. Check back for coverage of some additional presentations.
Axial Biotech (Salt Lake City, Utah) developed the ScoliScore test that predicts whether children diagnosed with Adolescent Idiopathic Scoliosis (AIS) are likely to progress to severe disease. Of the children that present as [...]